Monica Kwari

Statistics

Publications

Citations

2.6K

H-Index

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Irvine Medical Center

Cleveland Clinic

University of California, Irvine

Monica Kwari is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematologic malignancy therapy, and chemotherapy.

Publications per year

2002–2023

Publications

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Hagop M. Kantarjian, Deborah A. Thomas, Jeffrey L. Jorgensen et al. · The Lancet Oncology · 2012 · 412 citations

Medicine, Immunology, Oncology +14

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

Francesco Onida, Hagop M. Kantarjian, Terry L. Smith et al. · Blood · 2002 · 386 citations · Full text

Medicine, Hematology, Oncology +15

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

Hagop M. Kantarjian, Deborah A. Thomas, Jeffrey L. Jorgensen et al. · Cancer · 2013 · 302 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour, Nicholas J. Short, Nitin Jain et al. · The Lancet Haematology · 2022 · 239 citations

Medicine, Hematology, Oncology +12

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

Stefan Faderl, Varsha Gandhi, Susan O’Brien et al. · Blood · 2004 · 211 citations

Medicine, Oncology, Pharmacotherapy +10

1–5 of 28